CN116236536A - 一种抗病毒中药组合物、制剂及其制备方法 - Google Patents
一种抗病毒中药组合物、制剂及其制备方法 Download PDFInfo
- Publication number
- CN116236536A CN116236536A CN202310063256.6A CN202310063256A CN116236536A CN 116236536 A CN116236536 A CN 116236536A CN 202310063256 A CN202310063256 A CN 202310063256A CN 116236536 A CN116236536 A CN 116236536A
- Authority
- CN
- China
- Prior art keywords
- parts
- heat
- root
- water
- antiviral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 230000000840 anti-viral effect Effects 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 21
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 20
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 20
- 235000002226 Ranunculus ficaria Nutrition 0.000 claims abstract description 20
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 20
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 20
- 235000021419 vinegar Nutrition 0.000 claims abstract description 20
- 239000000052 vinegar Substances 0.000 claims abstract description 20
- 241000951473 Schizonepeta Species 0.000 claims abstract description 14
- 241000935235 Fritillaria meleagris Species 0.000 claims abstract description 13
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- 238000002791 soaking Methods 0.000 claims description 30
- 239000002994 raw material Substances 0.000 claims description 27
- 238000002156 mixing Methods 0.000 claims description 25
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 19
- 241001106477 Paeoniaceae Species 0.000 claims description 19
- 241001530126 Scrophularia Species 0.000 claims description 19
- 241000208843 Arctium Species 0.000 claims description 18
- 235000003130 Arctium lappa Nutrition 0.000 claims description 18
- 235000008078 Arctium minus Nutrition 0.000 claims description 18
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 17
- 235000011477 liquorice Nutrition 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 14
- 240000003582 Platycodon grandiflorus Species 0.000 claims description 14
- 244000246386 Mentha pulegium Species 0.000 claims description 10
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 10
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 235000001050 hortel pimenta Nutrition 0.000 claims description 10
- 235000020357 syrup Nutrition 0.000 claims description 10
- 239000006188 syrup Substances 0.000 claims description 10
- 241000576429 Forsythia suspensa Species 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 9
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 8
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 8
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 8
- 241001547125 Fritillaria thunbergii Species 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 6
- 235000010234 sodium benzoate Nutrition 0.000 claims description 6
- 239000004299 sodium benzoate Substances 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 238000009924 canning Methods 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000007670 refining Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 239000000341 volatile oil Substances 0.000 claims description 5
- 235000006751 Platycodon Nutrition 0.000 claims description 3
- 239000003443 antiviral agent Substances 0.000 claims description 3
- 229930189914 platycodon Natural products 0.000 claims description 3
- 244000274050 Platycodon grandiflorum Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 210000004072 lung Anatomy 0.000 abstract description 18
- 229940079593 drug Drugs 0.000 abstract description 17
- 208000011580 syndromic disease Diseases 0.000 abstract description 12
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 11
- 208000002193 Pain Diseases 0.000 abstract description 11
- 206010037660 Pyrexia Diseases 0.000 abstract description 11
- 230000001717 pathogenic effect Effects 0.000 abstract description 11
- 208000026435 phlegm Diseases 0.000 abstract description 11
- 206010068319 Oropharyngeal pain Diseases 0.000 abstract description 10
- 201000007100 Pharyngitis Diseases 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 206010022000 influenza Diseases 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 7
- 230000002588 toxic effect Effects 0.000 abstract description 7
- 206010046306 Upper respiratory tract infection Diseases 0.000 abstract description 5
- 210000001124 body fluid Anatomy 0.000 abstract description 5
- 239000010839 body fluid Substances 0.000 abstract description 5
- 238000001816 cooling Methods 0.000 abstract description 5
- 201000009240 nasopharyngitis Diseases 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 3
- 229940010454 licorice Drugs 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 3
- 230000002035 prolonged effect Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 7
- 206010036790 Productive cough Diseases 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 6
- 210000003800 pharynx Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010042674 Swelling Diseases 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 206010063659 Aversion Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 206010008479 Chest Pain Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 201000005505 Measles Diseases 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000003467 diminishing effect Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000357613 Platycodon Species 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 1
- 229960001627 lamivudine Drugs 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种抗病毒中药组合物、制剂及其制备方法,属于中医药技术领域。该组合物是以金银花和连翘为君药,用于清热解毒,疏散风热;桔梗、炒牛蒡子和薄荷共为臣药,疏风宣肺利咽;佐以荆芥疏风解表,浙贝母清热化瘀,再加入醋五味子、玄参、赤芍,具有益气生津、养阴凉血解毒之功效;甘草入肺经,有解毒清热,化痰止痛之功,并调和诸药为使。以上诸药合用,公奏清热解毒,疏风散热之效。具有清热解毒、消炎退热、祛邪解表的功能。可用于风热犯肺型急性上呼吸道感染、流行性感冒。主治风热感冒,流行性感冒。制剂为合剂,不仅提高了产品存储的有效时长,而且提高了使用和携带的便利性。
Description
技术领域
本发明属于中医药技术领域,具体涉及一种抗病毒中药组合物、制剂及其制备方法。
背景技术
大多数病毒对抗生素等西药不敏感,人们较难找到一种对细胞毒性较低而抗病毒活性较高的药物,用以对付各种原始的或新发现的微生物。虽然目前国内外研究的抗病毒药物已接近50种,但真正应用于临床的只有阿昔洛韦、拉米夫定等少数几类核苷类药物,而且,这类药物通常只能延缓病毒生长或减轻疾病症状,而且易产生耐药毒株,抗病毒谱窄,毒副作用大,价格高昂或药理特性不理想。
发明内容
本发明的第一目的在于提供一种抗病毒中药组合物,该中药组合物的主要治法和治则为:清热解毒、消炎退热、祛邪解表。
本发明的第二目的在于提供一种抗病毒制剂,该制剂可用于风热犯肺型急性上呼吸道感染、流行性感冒。主治风热感冒,流行性感冒,而且提高了产品存储的有效时长,而且提高了使用和携带的便利性。
本发明通过以下技术方案实现:
一种抗病毒中药组合物,所述组合物主要由以下质量份数的原料制备得到:
金银花14-35份、连翘14-35份、桔梗12-30份、炒牛蒡子12-30份、薄荷12-30份、荆芥12-30份、浙贝母12-30份、醋五味子14-35份、赤芍12-30份、玄参14-35份和甘草14-35份。
上述提供了一种抗病毒中药组合物,该组合物是以金银花和连翘为君药,用于清热解毒,疏散风热;桔梗、炒牛蒡子和薄荷共为臣药,疏风宣肺利咽;佐以荆芥疏风解表,浙贝母清热化瘀,再加入醋五味子、玄参、赤芍,具有益气生津、养阴凉血解毒之功效;甘草入肺经,有解毒清热,化痰止痛之功,并调和诸药为使。以上诸药合用,公奏清热解毒,疏风散热之效。具有清热解毒、消炎退热、祛邪解表的功能,可用于风热犯肺型急性上呼吸道感染、流行性感冒。主治风热感冒,流行性感冒。临床表现为:发热或高热、恶寒、头痛、鼻塞流涕、咽喉红肿疼痛、咳嗽、身痛等证属风热犯肺证者。
作为优选地,所述组合物主要由以下质量份数的原料制备得到:
金银花21份、连翘21份、桔梗18份、炒牛蒡子18份、薄荷18份、荆芥18份、浙贝母18份、醋五味子21份、赤芍18份、玄参21份和甘草21份。
金银花,具有清热解毒,疏散风热的功效。主治痈肿疔疮,外感风热,温病初起,热毒血痢。
连翘,具有清热解毒,消肿散结,疏散风热的功效。主治疮痈肿毒,瘰疬痰核,风热外感,温病初起,热淋涩痛。
桔梗,具有宣肺,祛痰,利咽,排脓的功效。主治咳嗽痰多,胸闷不畅,咽喉肿痛,失音,肺痈吐脓。
炒牛蒡子,具有疏散风热,宣肺祛痰,利咽透疹,解毒消肿的功效。主治风热感冒,温病初起,麻疹不透,风疹瘙痒,痈肿疮毒,丹毒,痄腮喉痹。
薄荷,具有疏散风热,清利头目,利咽透疹,疏肝行气的功效。主治风热感冒,温病初起,风热头痛,目赤多泪,咽喉肿痛,麻疹不透,风疹瘙痒,肝郁气滞、胸闷胁痛。
荆芥,具有祛风解表,透疹消疮,止血的功效。主治外感表证,麻疹不透,风疹瘙痒,疮疡初起兼有表证、吐衄下血。
浙贝母,具有清热化痰,散结消痈的功效。主治风热、痰热咳嗽,瘰疬,瘿瘤,乳痈疮毒,肺痈。
醋五味子,具有收敛固涩,益气生津,补肾宁心的功效。主治久咳虚喘,自汗,盗汗,遗精,滑精,久泻不止,津伤口渴,消渴,心悸,失眠,多梦。
赤芍,具有清热凉血,活血祛瘀的功效。主治温毒发斑,血热吐衄,目赤肿痛,痈肿疮疡,肝郁胁痛,经闭痛经,癥瘕腹痛,跌打损伤。
玄参,具有清热凉血,泻火解毒,滋阴的功效。主治温邪入营,内陷心包,温毒发斑,热病伤阴,津伤便秘,骨蒸劳嗽,目赤咽痛,瘰疬,白喉,痈肿疮毒。
甘草,具有益气补中,润肺止咳,清热解毒,缓急止痛,调和药性的功效。主治脾虚倦怠,心虚悸动,咳嗽气喘,痈疽喉痹,药食中毒,脘腹、四肢挛急疼痛等。
一种抗病毒制剂,包含所述的中药组合物。
一种抗病毒制剂的制备方法,包括:
1)按照相应的质量份数选取金银花、桔梗、炒牛蒡子、醋五味子、赤芍,玄参、甘草、浙贝母和连翘的生料混合后,加水浸泡,获得组分A;
2)按照相应的质量份数选取荆芥和薄荷的生料混合后,加水浸泡,采用蒸馏法提取挥发油,获得蒸馏液;
3)上述步骤(2)蒸馏后的残渣与组分A混合,加水煎煮、过滤、滤液静置后取上清液,浓缩成浸膏,与步骤(2)中获得的蒸馏液混合,获得组分B;
4)将蔗糖炼制成单糖浆后,在组分B中加入单糖浆、苯甲酸钠混匀,定容,罐装,包装,即得。
作为优选地,步骤1)中,所述金银花、桔梗、炒牛蒡子、醋五味子、赤芍,玄参、甘草、浙贝母和连翘的生料混合总质量与浸泡用水质量比为1:4;
所述加水浸泡时长为10-12h。
作为优选地,步骤2)中所述,荆芥和薄荷的生料混合总质量与浸泡用水质量比为1:4;
所述加水浸泡时长为0.5-0.8h。
作为优选地,步骤3)中,所述加水煎煮2次;
所述煎煮第一次30-35min;所述煎煮第二次50-60min。
作为优选地,步骤3)中,所述滤液静置6-7h。
作为优选地,所述制剂为合剂。
上述蔗糖炼制成单糖,是作为矫味剂和防止返砂的;苯甲酸钠用于防腐。
与现有技术相比,本发明至少具有如下技术效果:
本发明提供了一种抗病毒中药组合物,该组合物是以金银花和连翘为君药,用于清热解毒,疏散风热;桔梗、炒牛蒡子和薄荷共为臣药,疏风宣肺利咽;佐以荆芥疏风解表,浙贝母清热化瘀,再加入醋五味子、玄参、赤芍,具有益气生津、养阴凉血解毒之功效;甘草入肺经,有解毒清热,化痰止痛之功,并调和诸药为使。以上诸药合用,公奏清热解毒,疏风散热之效。
该中药组合物的主要治法和治则为:清热解毒、消炎退热、祛邪解表。
可用于风热犯肺型急性上呼吸道感染、流行性感冒。主治风热感冒,流行性感冒。临床表现为:发热或高热、恶寒、头痛、鼻塞流涕、咽喉红肿疼痛、咳嗽、身痛等证属风热犯肺证者。
上述该抗病毒制剂为合剂,不仅提高了产品存储的有效时长,而且提高了使用和携带的便利性。
具体实施方式
下面将结合实施例对本发明的实施方案进行详细描述,但是本领域技术人员将会理解,下列实施例仅用于说明本发明,而不应视为限制本发明的范围,实施例中未注明的具体条件,按照常规条件或者制造商建议的条件进行,所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
实施例1:
一种抗病毒中药组合物由以下质量份数的原料制备得到:
金银花140克、连翘140克、桔梗120克、炒牛蒡子120克、薄荷120克、荆芥120克、浙贝母120克、醋五味子140克、赤芍120克、玄参140克和甘草140克。
一种抗病毒制剂,包含所述的中药组合物。
一种抗病毒制剂的制备方法,包括:
1)按照相应的质量份数选取金银花、桔梗、炒牛蒡子、醋五味子、赤芍,玄参、甘草、浙贝母和连翘的生料混合后,加水浸泡,获得组分A;
2)按照相应的质量份数选取荆芥和薄荷的生料混合后,加水浸泡,采用蒸馏法提取挥发油,获得蒸馏液;
3)上述步骤(2)蒸馏后的残渣与组分A混合,加水煎煮、过滤、滤液静置后取上清液,浓缩成浸膏,与步骤(2)中获得的蒸馏液混合,获得组分B;
4)将蔗糖炼制成单糖浆后,在组分B中加入单糖浆、苯甲酸钠混匀,定容,罐装,包装,即得。
上述的一种具体实施方式,步骤1)中,所述金银花、桔梗、炒牛蒡子、醋五味子、赤芍,玄参、甘草、浙贝母和连翘的生料混合总质量与浸泡用水质量比为1:4;
所述加水浸泡时长为10h。
上述的一种具体实施方式,步骤2)中所述,荆芥和薄荷的生料混合总质量与浸泡用水质量比为1:4;
所述加水浸泡时长为0.5h。
上述的一种具体实施方式,步骤3)中,所述加水煎煮2次;
所述煎煮第一次30-min;所述煎煮第二次50min。
上述的一种具体实施方式,步骤3)中,所述滤液静置6h。
上述的一种具体实施方式,所述制剂为合剂。
实施例2:
一种抗病毒中药组合物由以下质量份数的原料制备得到:
金银花350克、连翘350克、桔梗300克、炒牛蒡子300克、薄荷300克、荆芥300克、浙贝母300克、醋五味子350克、赤芍300克、玄参350克和甘草350克。
一种抗病毒制剂,包含所述的中药组合物。
一种抗病毒制剂的制备方法,包括:
1)按照相应的质量份数选取金银花、桔梗、炒牛蒡子、醋五味子、赤芍,玄参、甘草、浙贝母和连翘的生料混合后,加水浸泡,获得组分A;
2)按照相应的质量份数选取荆芥和薄荷的生料混合后,加水浸泡,采用蒸馏法提取挥发油,获得蒸馏液;
3)上述步骤(2)蒸馏后的残渣与组分A混合,加水煎煮、过滤、滤液静置后取上清液,浓缩成浸膏,与步骤(2)中获得的蒸馏液混合,获得组分B;
4)将蔗糖炼制成单糖浆后,在组分B中加入单糖浆、苯甲酸钠混匀,定容,罐装,包装,即得。
上述的一种具体实施方式,步骤1)中,所述金银花、桔梗、炒牛蒡子、醋五味子、赤芍,玄参、甘草、浙贝母和连翘的生料混合总质量与浸泡用水质量比为1:4;
所述加水浸泡时长为12h。
上述的一种具体实施方式,步骤2)中所述,荆芥和薄荷的生料混合总质量与浸泡用水质量比为1:4;
所述加水浸泡时长为0.8h。
上述的一种具体实施方式,步骤3)中,所述加水煎煮2次;
所述煎煮第一次35min;所述煎煮第二次60min。
上述的一种具体实施方式,步骤3)中,所述滤液静置7h。
上述的一种具体实施方式,所述制剂为合剂。
实施例3:
一种抗病毒中药组合物由以下质量份数的原料制备得到:
金银花210克、连翘210克、桔梗180克、炒牛蒡子180克、薄荷180克、荆芥180克、浙贝母180克、醋五味子210克、赤芍180克、玄参210克和甘草210克。
一种抗病毒制剂,包含所述的中药组合物。
一种抗病毒制剂的制备方法,包括:
1)按照相应的质量份数选取金银花、桔梗、炒牛蒡子、醋五味子、赤芍,玄参、甘草、浙贝母和连翘的生料混合后,加水浸泡,获得组分A;
2)按照相应的质量份数选取荆芥和薄荷的生料混合后,加水浸泡,采用蒸馏法提取挥发油,获得蒸馏液;
3)上述步骤(2)蒸馏后的残渣与组分A混合,加水煎煮、过滤、滤液静置后取上清液,浓缩成浸膏,与步骤(2)中获得的蒸馏液混合,获得组分B;
4)将蔗糖炼制成单糖浆后,在组分B中加入单糖浆、苯甲酸钠混匀,定容,罐装,包装,即得。
上述的一种具体实施方式,步骤1)中,所述金银花、桔梗、炒牛蒡子、醋五味子、赤芍,玄参、甘草、浙贝母和连翘的生料混合总质量与浸泡用水质量比为1:4;
所述加水浸泡时长为12h。
上述的一种具体实施方式,步骤2)中所述,荆芥和薄荷的生料混合总质量与浸泡用水质量比为1:4;
所述加水浸泡时长为0.5-0.8h。
上述的一种具体实施方式,步骤3)中,所述加水煎煮2次;
所述煎煮第一次30min;所述煎煮第二次60min。
上述的一种具体实施方式,步骤3)中,所述滤液静置6h。
上述的一种具体实施方式,所述制剂为合剂。
使用方式:口服,3次/日,每次10-15mL,儿童酌减。
临床病例:
病例1:闫某某,女,32岁。
主诉:咽痛伴发热2天。
现病史:2天前出现咽痛,无咽痒、咽干,伴发热,体温最高39.0℃,偶有咳嗽,不频。
专科情况:体温37.6℃,咽红肿,双侧扁桃体无肿大,舌红,苔黄,脉浮数。
中医诊断:感冒,风热袭表证。
西医诊断:急性上呼吸道感染。
治疗方式:选用上述实施例3制备得到的合剂,口服,3次/日,每次10-15mL,服用3天。
治疗结果:上述病症消失。
病例2:陈某某,女,56岁。
主诉:咳嗽,咳痰2天。
现病史:2天前出现咳嗽,咳痰,咳黄痰,咽痛,偶有胸闷,无发热,未见其他不适,大小便正常。舌红,苔薄黄,脉浮数。
中医诊断:咳嗽,风热犯肺证。
治疗方式:选用上述实施例3制备得到的合剂,口服,3次/日,每次10-15mL,服用3天。
治疗结果:上述病症消失。
病例3:周某某,男,31岁。
主诉:咳嗽,咳痰1天。
现病史:1天前出现咳嗽,咳痰,咳黄稠痰,无畏寒发热,大小便正常。舌红,苔薄黄,脉浮数。
中医诊断:咳嗽,风热犯肺证。
治疗方式:选用上述实施例3制备得到的合剂,口服,3次/日,每次10-15mL,服用2天。
治疗结果:上述病症消失。
病例4:林某某,女,2岁2个月。
主诉:咳嗽,咳痰,咽痛3小时。
现病史:3小时前出现咳嗽,咳痰,咽痛,发热,体温38.5℃,无其他不适,大小便正常。咽部红肿,舌红,苔薄黄,脉浮数。
中医诊断:咳嗽,风热犯肺证。
治疗方式:选用上述实施例3制备得到的合剂,口服,1次/日,每次5-10mL,服用3天。
治疗结果:上述病症消失。
病例5:张某某,男,67岁。
主诉:咳嗽,咳痰,咽痛1天。
现病史:1天前出现咳嗽,咳黄痰,咽部疼痛,无畏寒发热,大小便正常。咽部红肿,舌红苔黄,脉浮数。
中医诊断:咳嗽,风热袭表证。
治疗方式:选用上述实施例3制备得到的合剂,口服,3次/日,每次10-15mL,服用3天。
治疗结果:上述病症消失。
最后应说明的是:以上所述仅为本发明的优选实施例而已,并不用于限制本发明的保护范围。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (9)
1.一种抗病毒中药组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
金银花14-35份、连翘14-35份、桔梗12-30份、炒牛蒡子12-30份、薄荷12-30份、荆芥12-30份、浙贝母12-30份、醋五味子14-35份、赤芍12-30份、玄参14-35份和甘草14-35份。
2.根据权利要求1所述的一种抗病毒中药组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
金银花21份、连翘21份、桔梗18份、炒牛蒡子18份、薄荷18份、荆芥18份、浙贝母18份、醋五味子21份、赤芍18份、玄参21份和甘草21份。
3.一种抗病毒制剂,其特征在于,包含权利要求1或2任一所述的中药组合物。
4.一种如权利要求3所述的抗病毒制剂的制备方法,其特征在于,包括:
1)按照相应的质量份数选取金银花、桔梗、炒牛蒡子、醋五味子、赤芍、玄参、甘草、浙贝母和连翘的生料混合后,加水浸泡,获得组分A;
2)按照相应的质量份数选取荆芥和薄荷的生料混合后,加水浸泡,采用蒸馏法提取挥发油,获得蒸馏液;
3)上述步骤(2)蒸馏后的残渣与组分A混合,加水煎煮、过滤、滤液静置后取上清液,浓缩成浸膏,与步骤(2)中获得的蒸馏液混合,获得组分B;
4)将蔗糖炼制成单糖浆后,在组分B中加入单糖浆、苯甲酸钠混匀,定容,罐装,包装,即得。
5.根据权利要求1所述的一种抗病毒制剂的制备方法,其特征在于,步骤1)中,所述金银花、桔梗、炒牛蒡子、醋五味子、赤芍、玄参、甘草、浙贝母和连翘的生料混合总质量与浸泡用水质量比为1:4;
所述加水浸泡时长为10-12h。
6.根据权利要求1所述的一种抗病毒制剂的制备方法,其特征在于,步骤2)中所述,荆芥和薄荷的生料混合总质量与浸泡用水质量比为1:4;
所述加水浸泡时长为0.5-0.8h。
7.根据权利要求1所述的一种抗病毒制剂的制备方法,其特征在于,步骤3)中,所述加水煎煮2次;
所述煎煮第一次30-35min;所述煎煮第二次50-60min。
8.根据权利要求1所述的抗病毒制剂的制备方法,其特征在于,步骤3)中,所述滤液静置6-7h。
9.根据权利要求1所述的一种抗病毒制剂的制备方法,其特征在于,所述制剂为合剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310063256.6A CN116236536A (zh) | 2023-01-13 | 2023-01-13 | 一种抗病毒中药组合物、制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310063256.6A CN116236536A (zh) | 2023-01-13 | 2023-01-13 | 一种抗病毒中药组合物、制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116236536A true CN116236536A (zh) | 2023-06-09 |
Family
ID=86625529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310063256.6A Pending CN116236536A (zh) | 2023-01-13 | 2023-01-13 | 一种抗病毒中药组合物、制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116236536A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744983A (zh) * | 2008-12-19 | 2010-06-23 | 潘绘中 | 一种治疗急性咽炎的中药配方 |
CN114288361A (zh) * | 2021-12-29 | 2022-04-08 | 江中药业股份有限公司 | 一种银翘解毒合剂及其制备方法 |
-
2023
- 2023-01-13 CN CN202310063256.6A patent/CN116236536A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744983A (zh) * | 2008-12-19 | 2010-06-23 | 潘绘中 | 一种治疗急性咽炎的中药配方 |
CN114288361A (zh) * | 2021-12-29 | 2022-04-08 | 江中药业股份有限公司 | 一种银翘解毒合剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103156984B (zh) | 用于治疗牙龈炎的中药组合物及其制备方法 | |
CN104642698A (zh) | 一种清热利咽解毒的糖果 | |
CN104983968B (zh) | 一种退热中药组合物及制备方法 | |
CN114917298B (zh) | 一种治疗肺炎的药物组合物及其制备方法 | |
CN101249255B (zh) | 一种治疗小儿咳嗽的中成药及其制备方法 | |
CN101653552B (zh) | 戒烟解毒中药制剂及其生产方法 | |
CN116236536A (zh) | 一种抗病毒中药组合物、制剂及其制备方法 | |
CN113616721A (zh) | 一种治疗口腔溃疡的药物组合物及其制备方法和应用 | |
CN108785559B (zh) | 一种治疗呼吸道感染的药物及其制备方法 | |
CN107753664B (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
CN110917271A (zh) | 一种用于儿童、青少年过敏性哮喘合并过敏性鼻炎防治的喷雾剂 | |
CN104623615A (zh) | 一种治疗哮喘的药物 | |
CN111228355A (zh) | 治疗心肺疾病的中药组合物及其制备方法、临床制剂 | |
CN116211993B (zh) | 老慢清组合物及其制备方法 | |
CN104225405A (zh) | 一种治疗呼吸道感染的中药含片及制备方法 | |
CN111298009A (zh) | 一种用于治疗小儿肺炎咳嗽的中药丸及其制备方法 | |
CN115317577B (zh) | 一种治疗小儿咳嗽的中药组合物 | |
CN108992580A (zh) | 用于化痰止咳的中药组合物及其制备方法 | |
CN112641855B (zh) | 一种用于治疗或预防感冒的中药组合物及其制备方法 | |
CN107582939B (zh) | 一种用于治疗慢性支气管炎的中药组合物及其制备方法 | |
CN111558012B (zh) | 一种治疗小儿支气管炎的中药组合物及其制备方法 | |
CN1245186C (zh) | 治疗急慢性咽炎的中药及其制备方法 | |
CN104906352A (zh) | 一种治疗虚火上炎型小儿口疮的中药药液及其制备方法 | |
CN104998189A (zh) | 一种治疗风热乘脾型小儿口疮的中药散剂及其制备方法 | |
CN104887808A (zh) | 一种治疗牙周炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |